Stimulation of immunity without alteration of oral tolerance in mice fed with heat-treated fermented infant formula

Journal of Pediatric Gastroenterology and Nutrition

Volumn 43, Issue 4, 2006, Pages 451-458

  Ménard, Sandrine ^a   Candalh, Céline ^a   Ahmed, Melika Ben ^a   Rakotobe, Sabine ^a,b   Gaboriau Routhiau, Valérie ^a,b   Cerf Bensussan, Nadine ^a   Heyman, Martine ^a  

^a INSERM   (France)

^b CEMAGREF   (France)

Author keywords

Fermented milk; Heat treated fermented infant formula; Infant nutrition; Lactic acid bacteria

Indexed keywords

ANTIGEN; GAMMA INTERFERON; HORSERADISH PEROXIDASE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 12P40; OVALBUMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; ARTIFICIAL MILK; BIFIDOBACTERIUM BREVE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FERMENTED PRODUCT; GENE EXPRESSION; HEAT TREATMENT; HOST RESISTANCE; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN PRODUCTION; IMMUNOLOGICAL TOLERANCE; IMMUNOSTIMULATION; INFANT NUTRITION; INGESTION; INTERFERON PRODUCTION; INTESTINE FUNCTION; INTESTINE MUCOSA PERMEABILITY; JEJUNUM; LACTIC ACID BACTERIUM; LONG TERM EXPOSURE; MACROMOLECULE; MOUSE; NONHUMAN; NUTRITIONAL TOLERANCE; PRIORITY JOURNAL; STREPTOCOCCUS THERMOPHILUS; VACCINATION;

ADMINISTRATION, ORAL; ANIMALS; ANTIGENS; BIFIDOBACTERIUM; CULTURED MILK PRODUCTS; CYTOKINES; FEMALE; IMMUNE TOLERANCE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INFANT FORMULA; INTESTINAL MUCOSA; MICE; MICE, INBRED C3H; MODELS, ANIMAL; OVALBUMIN; PERMEABILITY; STREPTOCOCCUS THERMOPHILUS;

ARMORACIA RUSTICANA; BIFIDOBACTERIUM BREVE; STREPTOCOCCUS THERMOPHILUS;

EID: 33750029994     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mpg.0000239738.71864.19     Document Type: Article

References (33)

1. Saavedra JM, Abi-Hanna A, Moore N, et al. Long-term consumption of infant formulas containing live probiotic bacteria: tolerance and safety. Am J Clin Nutr 2004;79:261-7.
2. Thibault H, Aubert-Jacquin C, Goulet O. Effects of long-term consumption of a fermented infant formula (with Bifidobacterium breve c50 and Streptococcus thermophilus 065) on acute diarrhea in healthy infants. J Pediatr Gastroenterol Nutr 2004;39:147-52.
3. Hooper LV, Wong MH, Thelin A, et al. Molecular analysis of commensal host-microbial relationships in the intestine. Science 2001;291:881-4.
4. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, et al. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004;118:229-41.
5. Tejada-Simon MV, Lee JH, Ustunol Z, et al. Ingestion of yogurt containing Lactobacillus acidophilus and Bifidobacterium to potentiate immunoglobulin A responses to cholera toxin in mice. J Dairy Sci 1999;82:649-60.
6. Kaila M, Isolauri E, Saxelin M, et al. Viable versus inactivated lactobacillus strain GG in acute rotavirus diarrhoea. Arch Dis Child 1995;72:51-3.
7. Kaila M, Isolauri E, Soppi E, et al. Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain. Pediatr Res 1992;32:141-4.
8. Mullie C, Yazourh A, Thibault H, et al. Increased poliovirusspecific intestinal antibody response coincides with promotion of Bifidobacterium longum-infantis and Bifidobacterium breve in infants: a randomized, double-blind, placebo-controlled trial. Pediatr Res 2004;56:791-5.
9. Fukushima Y, Kawata Y, Hara H, et al. Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children. Int J Food Microbiol 1998;42:39-44.
10. Haller D, Blum S, Bode C, et al. Activation of human peripheral blood mononuclear cells by nonpathogenic bacteria in vitro: evidence of NK cells as primary targets. Infect Immun 2000;68:752-9.
11. Hessle C, Hanson LA, Wold AE. Lactobacilli from human gastrointestinal mucosa are strong stimulators of IL-12 production. Clin Exp Immunol 1999;116:276-82.
12. Schiffrin EJ, Rochat F, Link-Amster H, et al. Immunomodulation of human blood cells following the ingestion of lactic acid bacteria. J Dairy Sci 1995;78:491-7.
13. Maassen CB, Holten-Neelen C, Balk F, et al. Strain-dependent induction of cytokine profiles in the gut by orally administered Lactobacillus strains. Vaccine 2000;18:2613-23.
14. Gallucci S, Matzinger P. Danger signals: SOS to the immune system. Curr Opin Immunol 2001;13:114-9.
15. Xia D, Sanders A, Shah M, et al. Real-time polymerase chain reaction analysis reveals an evolution of cytokine mRNA production in allograft acceptor mice. Transplantation 2001;72:907-14.
16. Maehly AC, Chance B. The assay of catalases and peroxidases. In: Glick D, ed. Methods of Biochemical Analysis. New York, NY: Wiley Intersciences, 1954:357-98. Vol 1.
17. Kalliomaki M, Salminen S, Arvilommi H, et al. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001;357:1076-9.
18. Kalliomaki M, Salminen S, Poussa T, et al. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 2003;361:1869-71.
19. Kirjavainen PV, Salminen SJ, Isolauri E. Probiotic bacteria in the management of atopic disease: underscoring the importance of viability. J Pediatr Gastroenterol Nutr 2003;36:223-7.
20. Terpend K, Blaton MA, Candalh C, et al. Intestinal barrier function and cow's milk sensitization in guinea-pigs fed milk or fermented milk. J Pediatr Gastroenterol Nut 1998;28:191-8.
21. Kweon MN, Fujihashi K, VanCott JL, et al. Lack of orally induced systemic unresponsiveness in IFN-gamma knockout mice. J Immunol 1998;160:1687-93.
22. Lee HO, Miller SD, Hurst SD, et al. Interferon gamma induction during oral tolerance reduces T-cell migration to sites of inflammation. Gastroenterology 2000;119:129-38.
23. Nilsen EM, Jahnsen FL, Lundin KE, et al. Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease. Gastroenterology 1998;115:551-63.
24. Chen W, Jin W, Hardegen N, et al. Conversion of peripheral CD4+CD25-naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003;198:1875-86.
25. Krieg AM, Hartmann G, Yi AK. Mechanism of action of CpG DNA. Curr Top Microbiol Immunol 2000;247:1-21.
26. Chu RS, Targoni OS, Krieg AM, et al. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J Exp Med 1997;186:1623-31.
27. Rachmilewitz D, Karmeli F, Takabayashi K, et al. Immunostimulatory DNA ameliorates experimental and spontaneous murine colitis. Gastroenterology 2002;122:1428-41.
28. Rachmilewitz D, Katakura K, Karmeli F, et al. Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 2004;126:520-8.
29. Katakura K, Lee J, Rachmilewitz D, et al. Toll-like receptor 9-induced type I IFN protects mice from experimental colitis. J Clin Invest 2005;115:695-702.
30. Madsen K, Cornish A, Soper P, et al. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 2001;121:580-91.
31. Terpend K, Boisgerault F, Blaton MA, et al. Protein transport and processing by human HT29-19A intestinal cells: effect of interferon gamma. Gut 1998;42:538-45.
32. Yan F, Polk DB. Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells. J Biol Chem 2002;277:50959-65.
33. Ichikawa H, Kuroiwa T, Inagaki A, et al. Probiotic bacteria stimulate gut epithelial cell proliferation in rat. Dig Dis Sci 1999;44:2119-23.